AI assistant
Cogent Biosciences, Inc. — Director's Dealing 2019
Jul 17, 2019
31688_dirs_2019-07-17_9de42c17-82cf-409d-8649-aeb3fe0cd0d5.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Unum Therapeutics Inc. (UMRX)
CIK: 0001622229
Period of Report: 2019-07-15
Reporting Person: Sachs Jessica (Chief Medical Officer)
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $4.39 | 2027-05-18 | Common Stock (63688) | Direct | |
| Stock Option (Right to Buy) | $9.77 | 2027-10-27 | Common Stock (12737) | Direct | |
| Stock Option (Right to Buy) | $12.00 | 2028-03-28 | Common Stock (21017) | Direct | |
| Stock Option (Right to Buy) | $3.60 | 2029-04-19 | Common Stock (21017) | Direct | |
| Stock Option (Right to Buy) | $3.52 | 2029-04-24 | Common Stock (22419) | Direct |
Footnotes
F1: 25% of the shares vested on April 18, 2018, and the remaining shares shall vest in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous service with the Issuer.
F2: 25% of the shares vested on October 27, 2018, and the remaining shares shall vest in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous service with the Issuer.
F3: 25% of the shares vested March 16, 2019, and the remaining shares shall vest in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous service with the Issuer.
F4: 25% of the shares shall vest on April 19, 2020, and the remaining shares shall vest in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous service with the Issuer.
F5: 25% of the shares shall vest on April 24, 2020, and the remaining shares shall vest in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous service with the Issuer.